Professional Documents
Culture Documents
Resuscitation
Conflict of Interest
No conflict of interest to declare.
www.PresentationPro.com
Contents
What are NOT considered best practices
Recommendations from AHA consensus statement
2013
Post-cardiac arrest MAP are we hitting the right
target?
Therapeutic Hypothermia post-cardiac arrest
www.PresentationPro.com
Standard
dose
adrenaline
vs
High dose
adrenaline
Lin S et al. Resuscitation. 2014;85(6):732-40.
Standard
dose
adrenaline
vs
Adre/Vaso
www.PresentationPro.com
Results
Adrenaline* vs placebo (1), n = 534
No difference in survival or neuro outcome
Historical Perspectives
Based on in-vitro, animal studies
1874, Pellacani - first to administer adrenal extract
to animals
1896, Gottlieb administered adrenal extract,
restored circulation after inducing hypotension
1906, Crile and Dolley the need of adrenaline to
restore aortic pressure
1963, Pearson and Reddings classic paper on
animal studies showed benefits of adrenaline
Am. Heart J. 1963 (66) 210214
www.PresentationPro.com
Authors Conclusion
There was no clear advantage of SDA over placebo, HDA,
adrenaline and vasopressin combination, or vasopressin
alone, in survival to discharge or neurological outcomes
after OHCA. There were improvements in rates of survival to
admission and ROSC with HDA over SDA and with SDA over
placebo. Thus, the efficacy of vasopressor use in OHCA
remains unanswered. Future trials are needed to determine
the optimal dose of adrenaline for OHCA.
*SDA = standard dose adrenaline;
HAD = high dose adrenaline
www.PresentationPro.com
Methods
10 studies, N = 32,993
No language limitation in article selection
P = Post-ROSC patients
I = Hyperoxia (PaO2 >300 mmHg)
C = Non-hyperoxia or Normoxia (60 300 mmHg)
O = In-hospital mortality (primary)
www.PresentationPro.com
In-Hospital Mortality
Non-Hyperoxia
Hyperoxia
www.PresentationPro.com
Methods
Prospective study
N = 2894 ventilated adult stroke
49% intracranial hemorrhage
32% subarachnoid hemorrhage
19% acute ischemic stroke
Results
Mortality was highest in the hyperoxia group
compared with the normoxia group (OR 1.7, 95%
CI 1.3-2.1;p < 0.0001) and the hypoxia group (OR
1.3; 95% CI 1.11.7]; p < 0.01.
www.PresentationPro.com
AVOID Study
AVOID Study
www.PresentationPro.com
www.PresentationPro.com
www.PresentationPro.com
Best Practices
Prevention of cardiac arrest: early identification of
deteriorations of vital signs or symptoms
Minimize interruptions in chest compression
Optimizes quality of depth of chest compression
Avoid hyperventilation
Early defibrillation
Debriefing and learning
Education, training, practice
Morrison LJ et al. Circulation. 2013;127(14):1538-63.
www.PresentationPro.com
www.PresentationPro.com
www.PresentationPro.com
Conclusions
As the authors have noted, it is hard to determine
from just this observational study whether these
parameters of MAP should guide interventions or
are merely prognostic.
But these data does support further studies of
maybe a relatively higher MAP should be targeted
after cardiac arrest.
www.PresentationPro.com
Historical Perspective
2 studies in Feb 2002 NEJM show improved
survival and neurological outcomes with induction
of mild therapeutic hypothermia for survivors of
OHCA
www.PresentationPro.com
Historical Perspective
The Hypothermia after Cardiac Arrest Study Group
study OHCA with ROSC: cooling to 32-34C over
24 hours in ED (n=137) improved functional
recovery at discharge (55% vs 39%; NNT = 6) and
lower 6-mo mortality rate vs with normothermic
patients (41% vs 55%) (NNT=7)
In Bernard et al, 77 OHCA with ROSC randomized
to hypothermia (33C for 12 hours) or to
normothermia. Good neurologic outcome at
discharge in 49% of hypothermic patients vs 26% of
normothermic patients.
www.PresentationPro.com
Summary
Not best practices:
Adrenaline Not shown to improve survival to
hospital discharge but give anyway. Higher chance
of ROSC than placebo.
High dose oxygen Bad! Higher risk of death!
Just aim for SaO2 92 94%
Oxygen is a drug. Not harmless!
www.PresentationPro.com
Summary
www.PresentationPro.com
Summary
Post-CA MAP: We may need to be aiming higher
than 65 mmHg. Inconclusive yet.
Therapeutic hypothermia: aiming to bring down
slightly to 36C is just as good as 33C
The beneficial effect may be due to the prevention
of post-CA hyperthermia rather than the cool 33C
per se
Therapeutic hypothermia may be de-emphasized in
the new AHA Guideline?
www.PresentationPro.com